216 related articles for article (PubMed ID: 24947892)
1. Favorable control of rapidly progressive retroperitoneal pleomorphic leiomyosarcoma with multimodality therapy: a case report.
Sagara K; Takayoshi K; Kusumoto E; Uchino K; Matsumura T; Kusaba H; Momosaki S; Ikejiri K; Baba E
BMC Res Notes; 2014 Jun; 7():377. PubMed ID: 24947892
[TBL] [Abstract][Full Text] [Related]
2. Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans-Atlantic RPS Working Group.
MacNeill AJ; Miceli R; Strauss DC; Bonvalot S; Hohenberger P; Van Coevorden F; Rutkowski P; Callegaro D; Hayes AJ; Honoré C; Fairweather M; Cannell A; Jakob J; Haas RL; Szacht M; Fiore M; Casali PG; Pollock RE; Raut CP; Gronchi A; Swallow CJ
Cancer; 2017 Jun; 123(11):1971-1978. PubMed ID: 28152173
[TBL] [Abstract][Full Text] [Related]
3. Modern multimodality management of patients with caval leiomyosarcoma: New treatment paradigms and potential molecular insights.
Squires MH; Politano S; Pollock RE; Chen JL; Grignol V
J Surg Oncol; 2021 Jun; 123(7):1618-1623. PubMed ID: 33650695
[TBL] [Abstract][Full Text] [Related]
4. Multimodal treatment with doxorubicin, cisplatin, and ifosfamide for the treatment of advanced or metastatic uterine leiomyosarcoma: a unicentric experience.
Hadoux J; Rey A; Duvillard P; Lhommé C; Balleyguier C; Haie-Meder C; Morice P; Tazi Y; Leary A; Larue C; Pautier P
Int J Gynecol Cancer; 2015 Feb; 25(2):296-302. PubMed ID: 25581897
[TBL] [Abstract][Full Text] [Related]
5. Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcoma.
Akin S; Dizdar O; Karakas Y; Turker A; Kars A
Curr Probl Cancer; 2018; 42(3):344-349. PubMed ID: 29576383
[TBL] [Abstract][Full Text] [Related]
6. Proton-beam, intensity-modulated, and/or intraoperative electron radiation therapy combined with aggressive anterior surgical resection for retroperitoneal sarcomas.
Yoon SS; Chen YL; Kirsch DG; Maduekwe UN; Rosenberg AE; Nielsen GP; Sahani DV; Choy E; Harmon DC; DeLaney TF
Ann Surg Oncol; 2010 Jun; 17(6):1515-29. PubMed ID: 20151216
[TBL] [Abstract][Full Text] [Related]
7. Significance of intraoperative radiation therapy and high cumulative radiation doses in retroperitoneal soft tissue sarcoma.
Willis F; Schimmack S; Uhl M; Haefner MF; Mechtersheimer G; Hinz U; Schmidt T; Debus J; Fröhling S; Schneider M
Eur J Surg Oncol; 2020 May; 46(5):905-913. PubMed ID: 31892479
[TBL] [Abstract][Full Text] [Related]
8. Oncology outcomes in Retroperitoneal sarcomas: Prognostic factors in a Retrospective Cohort study.
Garcia-Ortega DY; Villa-Zepeda O; Martinez-Said H; Cuellar-Hübbe M; Luna-Ortiz K
Int J Surg; 2016 Aug; 32():45-9. PubMed ID: 27268726
[TBL] [Abstract][Full Text] [Related]
9. Intensity modulated radiation therapy and surgery for Management of Retroperitoneal Sarcomas: a single-institution experience.
Cosper PF; Olsen J; DeWees T; Van Tine BA; Hawkins W; Michalski J; Zoberi I
Radiat Oncol; 2017 Dec; 12(1):198. PubMed ID: 29216884
[TBL] [Abstract][Full Text] [Related]
10. Impact of chemotherapy on survival in surgically resected retroperitoneal sarcoma.
Miura JT; Charlson J; Gamblin TC; Eastwood D; Banerjee A; Johnston FM; Turaga KK
Eur J Surg Oncol; 2015 Oct; 41(10):1386-92. PubMed ID: 26251340
[TBL] [Abstract][Full Text] [Related]
11. Retroperitoneal sarcomas: from diagnosis to treatment. Case series and review of the literature.
Mantas D; Garmpis N; Polychroni D; Garmpi A; Damaskos C; Liakea A; Sypsa G; Kouskos E
G Chir; 2020; 41(1):18-33. PubMed ID: 32038009
[TBL] [Abstract][Full Text] [Related]
12. Retroperitoneal sarcomas: a reappraisal of treatment.
Storm FK; Eilber FR; Mirra J; Morton DL
J Surg Oncol; 1981; 17(1):1-7. PubMed ID: 7230826
[TBL] [Abstract][Full Text] [Related]
13. Retroperitoneal soft tissue sarcomas: prognosis and treatment of primary and recurrent disease in 117 patients.
Alldinger I; Yang Q; Pilarsky C; Saeger HD; Knoefel WT; Peiper M
Anticancer Res; 2006; 26(2B):1577-81. PubMed ID: 16619574
[TBL] [Abstract][Full Text] [Related]
14. [A case of retroperitoneal leiomyosarcoma with abdominal wall recurrence 7 years after the first operation].
Kishimoto N; Takao T; Hayashi T; Yamaguchi Y; Miyagawa Y; Tsujimura A; Nonomura N
Hinyokika Kiyo; 2012 Sep; 58(9):487-90. PubMed ID: 23070387
[TBL] [Abstract][Full Text] [Related]
15. [Recurrence of a Giant Retroperitoneal Leiomyosarcoma Six Years after the Initial Surgery].
Adikrisna R; Sugishita T; Takahara H; Kakuta S; Murase Y; Watanabe Y; Udagawa M
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1739-1741. PubMed ID: 29394760
[TBL] [Abstract][Full Text] [Related]
16. Resectable retroperitoneal soft tissue sarcomas. The effect of extent of resection and postoperative radiation therapy on local tumor control.
van Doorn RC; Gallee MP; Hart AA; Gortzak E; Rutgers EJ; van Coevorden F; Keus RB; Zoetmulder FA
Cancer; 1994 Feb; 73(3):637-42. PubMed ID: 8299085
[TBL] [Abstract][Full Text] [Related]
17. Retroperitoneal sarcoma: is it time to change the surgical policy?
Mussi C; Colombo P; Bertuzzi A; Coladonato M; Bagnoli P; Secondino S; Navarria P; Morenghi E; Santoro A; Quagliuolo V
Ann Surg Oncol; 2011 Aug; 18(8):2136-42. PubMed ID: 21537866
[TBL] [Abstract][Full Text] [Related]
18. [Huge retroperitoneal leiomyosarcoma: a case report].
Hashimoto T; Yamamoto S; Togo Y; Ueda Y; Higuchi Y; Maruyama T; Kondoh N; Nojima M; Mori Y; Shincho M; Hao H; Hirota S; Shima H
Hinyokika Kiyo; 2007 Mar; 53(3):167-9. PubMed ID: 17447485
[TBL] [Abstract][Full Text] [Related]
19. Retroperitoneal sarcoma: 25 years of experience with aggressive surgical treatment at the Institute of Oncology, Ljubljana.
Erzen D; Sencar M; Novak J
J Surg Oncol; 2005 Jul; 91(1):1-9. PubMed ID: 15999353
[TBL] [Abstract][Full Text] [Related]
20. Significant benefits in survival by the use of surgery combined with radiotherapy for retroperitoneal soft tissue sarcoma.
Hager S; Makowiec F; Henne K; Hopt UT; Wittel UA
Radiat Oncol; 2017 Jan; 12(1):29. PubMed ID: 28126006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
